novel
coronavirusinduc
pneumonia
name
coronaviru
diseas
februari
rapidli
increas
epidem
scale
sinc
first
appear
wuhan
china
decemb
day
intern
viru
classif
commiss
announc
novel
coronaviru
name
sever
acut
respiratori
syndrom
coronaviru
first
sever
respiratori
diseas
outbreak
caus
coronaviru
past
two
decad
coronavirus
caus
three
epidem
diseas
name
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
present
case
found
mani
countri
around
world
accord
latest
data
march
number
confirm
case
china
reach
dead
cure
addit
china
number
confirm
case
countri
also
reach
dead
cure
januari
world
health
organ
announc
list
public
health
emerg
intern
concern
pheic
mean
may
pose
risk
multipl
countri
requir
coordin
intern
respons
review
tri
explain
molecular
immun
pathogenesi
diagnosi
provid
refer
prevent
drug
develop
infect
base
recent
research
progress
knowledg
research
sarscov
merscov
coronavirus
envelop
virus
posit
sens
singlestrand
rna
genom
kb
four
coronaviru
genera
b
g
identifi
far
human
coronavirus
hcov
detect
coronaviru
b
coronaviru
merscov
sarscov
genera
late
decemb
patient
present
cough
fever
dyspnea
acut
respiratori
distress
syndrom
ard
due
unidentifi
microbi
infect
report
wuhan
china
viru
genom
sequenc
five
patient
pneumonia
hospit
decemb
decemb
reveal
presenc
previous
unknown
bcov
strain
isol
novel
bcov
show
ident
sequenc
two
batderiv
sever
acut
respiratori
syndrom
sar
like
coronavirus
ident
sequenc
merscov
novel
bcov
name
intern
viru
classif
commiss
phylogenet
tree
sarslik
coronavirus
complet
genom
sequenc
clearli
depict
fig
genom
similar
typic
cov
contain
least
ten
open
read
frame
orf
first
orf
twothird
viral
rna
translat
two
larg
polyprotein
sarscov
merscov
two
polyprotein
process
nonstructur
protein
form
viral
replicas
transcriptas
complex
nsp
rearrang
membran
origin
rough
endoplasm
reticulum
rer
doublemembran
vesicl
viral
replic
transcript
occur
orf
onethird
genom
encod
four
main
structur
protein
spike
envelop
e
nucleocapsid
n
membran
protein
well
sever
accessori
protein
unknown
function
particip
viral
replic
fig
sever
group
scientist
china
discov
like
sarscov
requir
angiotensinconvert
enzym
receptor
enter
cell
bind
viru
host
cell
receptor
signific
determin
pathogenesi
infect
sarscov
like
origin
bat
adapt
nonbat
variant
cross
speci
infect
human
dipeptidyl
peptidas
also
known
identifi
function
receptor
merscov
receptorbind
domain
merscov
spike
protein
copurifi
specif
lysat
suscept
cell
merscov
bind
multipl
speci
promot
transmiss
human
speci
infect
cell
larg
number
speci
better
understand
rel
effect
receptor
bind
proteas
action
help
predict
whether
specif
zoonot
coronavirus
infect
human
possibl
adapt
patient
show
clinic
manifest
includ
fever
nonproduct
cough
dyspnea
myalgia
fatigu
normal
decreas
leukocyt
count
radiograph
evid
pneumonia
similar
symptom
sarscov
merscov
infect
henc
although
pathogenesi
poorli
understood
similar
mechan
sarscov
merscov
still
give
us
lot
inform
pathogenesi
infect
facilit
recognit
coronaviru
protein
report
signific
determin
viru
entri
host
cell
envelop
spike
glycoprotein
bind
cellular
receptor
sarscov
ctype
lectin
also
call
lsign
sarscov
merscov
entri
sarscov
cell
initi
identifi
accomplish
direct
membran
fusion
viru
plasma
membran
belouzard
et
al
found
critic
proteolyt
cleavag
event
occur
sarscov
protein
posit
mediat
membran
fusion
viral
infect
merscov
also
evolv
abnorm
twostep
furin
activ
membran
fusion
besid
membran
fusion
clathrindepend
independ
endocytosi
mediat
sarscov
entri
viru
enter
cell
viral
rna
genom
releas
cytoplasm
translat
two
polyprotein
structur
protein
viral
genom
begin
replic
newli
form
envelop
glycoprotein
insert
membran
endoplasm
reticulum
golgi
nucleocapsid
form
combin
genom
rna
nucleocapsid
protein
viral
particl
germin
endoplasm
reticulumgolgi
intermedi
compart
ergic
last
vesicl
contain
viru
particl
fuse
plasma
membran
releas
viru
viru
enter
cell
antigen
present
antigen
present
cell
apc
central
part
bodi
antivir
immun
antigen
peptid
present
major
histocompat
complex
mhc
human
leukocyt
antigen
hla
human
recogn
virusspecif
cytotox
lymphocyt
ctl
henc
understand
antigen
present
help
comprehens
pathogenesi
unfortun
still
lack
report
get
inform
previou
research
sarscov
merscov
antigen
present
sarscov
mainli
depend
mhc
molecul
mhc
ii
also
contribut
present
previou
research
show
numer
hla
polymorph
correl
suscept
sarscov
hlab
hlab
hladr
hlacw
wherea
hlaa
allel
relat
protect
sar
infect
merscov
infect
mhc
ii
molecul
associ
suscept
merscov
infect
besid
gene
polymorph
mbl
mannosebind
lectin
associ
antigen
present
relat
risk
sarscov
infect
research
provid
valuabl
clue
prevent
treatment
mechan
antigen
present
subsequ
stimul
bodi
humor
cellular
immun
mediat
virusspecif
b
cell
similar
common
acut
viral
infect
antibodi
profil
sarscov
viru
typic
pattern
igm
igg
product
sarsspecif
igm
antibodi
disappear
end
week
igg
antibodi
last
long
time
indic
igg
antibodi
may
mainli
play
protect
role
sarsspecif
igg
antibodi
primarili
sspecif
nspecif
antibodi
compar
humor
respons
research
cellular
immun
coronaviru
latest
report
show
number
cell
peripher
blood
patient
significantli
reduc
wherea
statu
excess
activ
evidenc
high
proport
hladr
doubleposit
fraction
similarli
acut
phase
respons
patient
sarscov
associ
sever
decreas
cell
even
antigen
memori
cell
persist
four
year
part
sarscov
recov
individu
perform
cell
prolifer
dth
respons
product
ifng
six
year
sarscov
infect
specif
tcell
memori
respons
sarscov
peptid
librari
could
still
identifi
recov
sar
patient
specif
cell
also
show
similar
effect
merscov
clearanc
mice
find
may
provid
valuabl
inform
ration
design
vaccin
report
lancet
show
ard
main
death
caus
patient
admit
earli
stage
outbreak
six
die
ard
ard
common
immunopatholog
event
sarscov
merscov
infect
one
main
mechan
ard
cytokin
storm
deadli
uncontrol
system
inflammatori
respons
result
releas
larg
amount
proinflammatori
cytokin
ifna
ifng
tnfa
tgfb
etc
chemokin
etc
immun
effector
cell
sarscov
infect
similar
sarscov
individu
sever
merscov
infect
show
elev
level
ifna
serum
compar
mildmoder
diseas
cytokin
storm
trigger
violent
attack
immun
system
bodi
caus
ard
multipl
organ
failur
final
lead
death
sever
case
infect
like
occur
sarscov
merscov
infect
better
surviv
host
cell
sarscov
merscov
use
multipl
strategi
avoid
immun
respons
evolutionarili
conserv
microbi
structur
call
pathogenassoci
molecular
pattern
pamp
recogn
pattern
recognit
receptor
prr
howev
sarscov
merscov
induc
product
doublemembran
vesicl
lack
prr
replic
vesicl
therebi
avoid
host
detect
dsrna
ifni
ifna
ifnb
protect
effect
sarscov
merscov
infect
ifni
pathway
inhibit
infect
mice
accessori
protein
merscov
may
block
induct
ifn
level
activ
direct
interact
doublestrand
rna
besid
membran
protein
merscov
inhibit
nuclear
transport
ifn
regulatori
factor
activ
ifn
b
promot
antigen
present
also
affect
coronaviru
exampl
gene
express
relat
antigen
present
downregul
merscov
infect
therefor
destroy
immun
evas
imper
treatment
specif
drug
develop
clinic
diagnosi
mainli
base
epidemiolog
histori
clinic
manifest
auxiliari
examin
nucleic
acid
detect
ct
scan
immun
identif
technolog
pointofcar
test
poct
igmigg
enzymelink
immunosorb
assay
elisa
blood
cultur
howev
clinic
symptom
sign
patient
infect
highli
atyp
includ
respiratori
symptom
cough
fever
dyspnea
viral
pneumonia
therefor
auxiliari
examin
necessari
diagnosi
epidemiolog
histori
two
commonli
use
nucleic
acid
detect
technolog
realtim
quantit
polymeras
chain
reaction
rtqpcr
highthroughput
sequenc
authorit
identif
method
viru
blood
cultur
highthroughput
sequenc
whole
genom
howev
applic
highthroughput
sequenc
technolog
clinic
diagnosi
limit
equip
depend
high
cost
rtqpcr
common
effect
straightforward
method
detect
pathogen
virus
respiratori
secret
blood
outbreak
china
mani
compani
soon
launch
rtqpcr
test
kit
clinic
diagnosi
chines
center
diseas
control
prevent
china
cdc
recommend
use
specif
primer
probe
n
gene
region
detect
rtqpcr
patient
defin
laboratoryconfirm
infect
target
posit
http
chu
et
al
describ
two
rtqpcr
assay
taqmanbas
fluoresc
signal
detect
two
differ
region
n
viral
genom
separ
neg
control
sampl
confirm
neg
one
sampl
two
infect
patient
confirm
posit
one
respiratori
specimen
method
anoth
studi
show
posit
rate
patient
selfcollect
saliva
use
rtqpcr
nonprob
sybr
base
fluoresc
signal
suggest
saliva
promis
noninvas
specimen
diagnosi
monitor
infect
control
patient
infect
rtqpcr
detect
also
show
high
sensit
specif
sarscov
merscov
infect
howev
five
patient
neg
result
rtqpcr
may
present
posit
chest
ct
find
repeat
swab
test
rtqpcr
eventu
confirm
patient
infect
detect
sarscov
use
rtqpcr
achiev
sensit
depend
protocol
use
sampl
type
number
clinic
specimen
collect
thu
essenti
improv
detect
rate
rtqpcr
infect
besid
rtqpcr
shortcom
includ
certain
biolog
safeti
hazard
brought
retent
oper
patient
sampl
cumbersom
nucleic
acid
detect
oper
long
wait
time
result
diagnosi
although
rtqpcr
specif
falseneg
rate
ignor
sever
consequ
miss
diagnosi
mani
clinician
propos
ct
scan
one
necessari
auxiliari
diagnost
method
sensit
individu
high
clinic
suspicion
infect
neg
rtqpcr
screen
combin
repeat
rtqpcr
test
chest
ct
scan
may
help
especi
highresolut
ct
hrct
chest
essenti
earli
diagnosi
evalu
diseas
sever
patient
sever
studi
analyz
chest
ct
imag
patient
infect
typic
ct
imag
show
bilater
pulmonari
parenchym
groundglass
consolid
pulmonari
opac
sometim
round
morpholog
peripher
lung
distribut
lung
involv
peripher
predomin
also
seen
patient
sarscov
merscov
infect
chest
ct
show
diseas
progress
groundglass
opac
consolid
similar
infect
accord
find
ct
scan
great
clinic
diagnost
valu
especi
high
preval
area
infect
howev
ct
scan
also
shortcom
indistinguish
viral
pneumonia
hysteresi
abnorm
ct
imag
given
shortcom
current
use
nucleic
acid
detect
ct
scan
diagnosi
clinic
laboratori
appli
immunolog
detect
kit
target
viral
antigen
antibodi
soon
possibl
current
poct
igmigg
elisa
kit
develop
pretest
compani
shown
higher
detect
rate
nucleic
acid
detect
still
product
publish
articl
sensit
sarscov
nbase
igg
elisa
significantli
higher
sarscov
sbase
igg
elisa
sensit
igg
igm
remain
studi
henc
develop
sensit
specif
auxiliari
method
necessari
urgent
diagnosi
like
sarscov
merscov
current
clinic
proven
specif
antivir
agent
avail
infect
support
treatment
includ
oxygen
therapi
conserv
fluid
manag
use
broadspectrum
antibiot
cover
secondari
bacteri
infect
remain
import
manag
strategi
accord
research
molecular
mechan
coronaviru
infect
genom
organ
sever
potenti
therapeut
target
repurpos
exist
antivir
agent
develop
effect
intervent
novel
coronaviru
remdesivir
adenosin
analogu
target
rnadepend
rna
polymeras
block
viral
rna
synthesi
promis
antivir
drug
wide
array
rna
virus
includ
sarsmerscov
infect
cultur
cell
mice
nonhuman
primat
model
washington
depart
health
administr
remdesivir
intraven
first
found
remdesivir
might
potenti
protect
infect
remdesivir
chloroquin
demonstr
inhibit
effect
vitro
henc
nucleosid
analogu
favipiravir
ribavirin
galidesivir
may
potenti
clinic
applic
chymotrypsinlik
proteas
papainlik
proteas
plp
nonstructur
protein
essenti
function
coronavir
replic
inhibit
host
innat
immun
respons
inhibitor
cinanserin
flavonoid
plp
inhibitor
diarylheptanoid
attract
choic
fight
mediat
entri
cell
function
receptor
coronavirus
block
bind
protein
also
meaning
strategi
infect
also
report
mani
convalesc
patient
donat
plasma
sarscov
merscov
trial
preliminari
acquir
favor
result
acut
sever
patient
moreov
gener
recombin
human
monoclon
antibodi
mab
fairli
straightforward
path
neutral
sarscov
sar
coronavirusspecif
human
monoclon
antibodi
bind
potent
receptorbind
domain
rbd
potenti
develop
candid
therapeut
infect
monoclon
antibodi
neutral
sarscov
could
altern
treatment
effect
vaccin
essenti
reduc
diseas
sever
viral
shed
transmiss
thu
help
control
coronaviru
outbreak
sever
vaccin
strategi
sarscov
merscov
test
anim
includ
liveattenu
viru
viral
vector
inactiv
viru
subunit
vaccin
recombin
dna
protein
vaccin
studi
progress
requir
month
year
develop
vaccin
current
may
mani
promis
target
laboratori
clinic
evid
still
explor
work
chines
scientist
launch
clinic
trial
potenti
treatment
tradit
chines
medicin
seem
effect
support
treatment
new
pharmaceut
drug
includ
hiv
drug
stem
cell
testifi
clinic
trial
conclus
occurr
develop
depend
interact
viru
individu
immun
system
viral
factor
includ
viru
type
mutat
viral
load
viral
titer
viabil
viru
vitro
individu
immun
system
factor
includ
genet
hla
gene
age
gender
nutrit
statu
neuroendocrineimmun
regul
physic
statu
factor
contribut
whether
individu
infect
viru
durat
sever
diseas
reinfect
earli
stage
epidem
accur
diagnosi
help
control
spread
diseas
imper
develop
new
safe
accur
fast
simpl
new
technolog
detect
cours
physician
intent
interven
two
factor
make
develop
direct
benefici
human
health
help
patient
recov
soon
possibl
howev
must
consid
medic
intervent
achiev
cur
effect
author
declar
conflict
interest
